MRI Access

MRI ACCESS Implantable Cardiac Devices

Cardiology and Radiology

Unmatched MRI Access

Annually, 12-16% of device patients are likely to have an MRI ordered.1-4 Historically, less than 1% would have received a scan.1-4 Today, with our exclusive MRI portfolio, you can ensure safe MRI access for the most patients when MR conditions are met.

Medtronic has long been committed to providing cardiac device patients with access to the diagnostic and treatment benefits of MRI. Our portfolio of cardiac resynchronization therapy defibrillator (CRT-D), implantable cardioverter defibrillator (ICD), pacing, and insertable cardiac monitor (ICM) systems provides exactly that — safe, full body MRI access.

  • No MRI exclusion zone
  • SureScan devices and leads that work in any combination
  • 1.5T and 3T full body MRI scanning across the portfolio

 


pdf MR-Conditional Cardiac Device Summary Chart (.pdf)

For a full listing of our implantable cardiac devices that are approved for use in the MR environment, download our MR-Conditional Cardiac Device Summary Chart.

331KB


One day your patient may need and MRI

  

In 2011 we launched the first pacemaker in Canada  that was safe to use in an MRI.

We didn’t stop there. 

  • We did the same for our neurostimulator in 2013
  •  Our insertable cardiac monitor in 2014
  • Our implantable cardioverter defibrillator (ICD) in 2015
  • The only cardiac resynchronyzation therapy-defibrillator (CRT-D) in 2017

Now, more Canadians with these medical devices can access an MRI.


MRI Need for Pacemaker, ICD, and CRT Patients

With SureScan pacemakers, patients are now receiving MRIs

*Pacemakers and ICDs: Patient cohorts were matched so both represent a group of patients with the same 1) Gender, 2) Age, 3) Major comorbidities

†CRT-Ds: Data from 2012 were used to project MRI utilization in the CRT patient cohort over 1 year; whereas the actual MRI utilization rate over 1 year was measured in the non-CRT cohort.

SureScan Technology–Supported by Extensive Evidence and Experience

3,739 SureScan Patients Studied

 


1

Data from 2010 MarketScan® Commercial and Medicare databases from Truven Health Analytics, Inc. were used to characterize non-pacemaker and pacemaker cohorts and utilization or radiology services. Cohorts were matched based on age, gender, and comorbidities.

2

Medtronic data on file 2015: ICD data from MarketScan® 2012 Commercial and Medicare Database, Truven Health Analytics.

3

Nazarian S, Reynolds MR, Ryan MP, et al. Utilization and likelihood of radiologic diagnostic imaging in patients with implantable cardiac defibrillators. J Magn Reson Imaging. January 2016;43(1):115-127.

4

Medtronic data on file 2015: CRT data from MarketScan® 2012 Commercial and Medicare Database, Truven Health Analytics.

5

Ramza B, et al. Are There Cumulative Effects of Multiple MRI on MR-conditional Pacemakers? Presented at HRS, May 2014.

6

Gold MR, Sommer T, Schwitter J, et al. Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator: Primary Results of a Randomized Study. J Am Coll Cardiol. June 23, 2015; 65(24):2581-2588.

7

Shenthar J, Milasinovic G, Al Fagih A, et al. MRI scanning in patients with new and existing CapSureFix Novus 5076 pacemaker leads: randomized trial results. Heart Rhythm. April 2015;12(4):759-765.

8

Gimbel JR, Bello D, Schmitt M, et al. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla. Heart Rhythm. May 2013;10(5):685-691.

9

Wilkoff BL, Bello D, Taborsky M, et al. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm. January 2011;8(1):65-73.